BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blazeski A, Zhu R, Hunter DW, Weinberg SH, Boheler KR, Zambidis ET, Tung L. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog Biophys Mol Biol. 2012;110:178-195. [PMID: 22958937 DOI: 10.1016/j.pbiomolbio.2012.07.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu F, Fang Y, Hou X, Yan Y, Xiao H, Zuo D, Wen J, Wang L, Zhou Z, Dang X, Zhou R, Liao B. Enrichment differentiation of human induced pluripotent stem cells into sinoatrial node-like cells by combined modulation of BMP, FGF, and RA signaling pathways. Stem Cell Res Ther 2020;11:284. [PMID: 32678003 DOI: 10.1186/s13287-020-01794-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Aigha I, Raynaud C. Maturation of pluripotent stem cell derived cardiomyocytes: The new challenge. Glob Cardiol Sci Pract 2016;2016:e201606. [PMID: 29043256 DOI: 10.21542/gcsp.2016.6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Abbate E, Boulakia M, Coudière Y, Gerbeau JF, Zitoun P, Zemzemi N. In silico assessment of the effects of various compounds in MEA/hiPSC-CM assays: Modeling and numerical simulations. J Pharmacol Toxicol Methods 2018;89:59-72. [PMID: 29066291 DOI: 10.1016/j.vascn.2017.10.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Robertson C, Tran DD, George SC. Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells. 2013;31:829-837. [PMID: 23355363 DOI: 10.1002/stem.1331] [Cited by in Crossref: 222] [Cited by in F6Publishing: 208] [Article Influence: 31.7] [Reference Citation Analysis]
5 Li X, Gao F, Wang X, Liang Q, Bai A, Liu Z, Chen X, Li E, Chen S, Lu C, Qian R, Sun N, Liang P, Xu C. E2A ablation enhances proportion of nodal-like cardiomyocytes in cardiac-specific differentiation of human embryonic stem cells. EBioMedicine 2021;71:103575. [PMID: 34488017 DOI: 10.1016/j.ebiom.2021.103575] [Reference Citation Analysis]
6 Liu J, Laksman Z, Backx PH. The electrophysiological development of cardiomyocytes. Adv Drug Deliv Rev 2016;96:253-73. [PMID: 26788696 DOI: 10.1016/j.addr.2015.12.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
7 Yoshida Y, Yamanaka S. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications. Circ Res 2017;120:1958-68. [DOI: 10.1161/circresaha.117.311080] [Cited by in Crossref: 132] [Cited by in F6Publishing: 82] [Article Influence: 33.0] [Reference Citation Analysis]
8 Kirkton RD, Badie N, Bursac N. Spatial profiles of electrical mismatch determine vulnerability to conduction failure across a host-donor cell interface. Circ Arrhythm Electrophysiol 2013;6:1200-7. [PMID: 24235268 DOI: 10.1161/CIRCEP.113.001050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Lippi M, Stadiotti I, Pompilio G, Sommariva E. Human Cell Modeling for Cardiovascular Diseases. Int J Mol Sci 2020;21:E6388. [PMID: 32887493 DOI: 10.3390/ijms21176388] [Reference Citation Analysis]
10 Ribeiro AJS, Guth BD, Engwall M, Eldridge S, Foley CM, Guo L, Gintant G, Koerner J, Parish ST, Pierson JB, Brock M, Chaudhary KW, Kanda Y, Berridge B. Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes. Front Pharmacol 2019;10:934. [PMID: 31555128 DOI: 10.3389/fphar.2019.00934] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
11 Radaszkiewicz KA, Sýkorová D, Karas P, Kudová J, Kohút L, Binó L, Večeřa J, Víteček J, Kubala L, Pacherník J. Simple non-invasive analysis of embryonic stem cell-derived cardiomyocytes beating in vitro. Review of Scientific Instruments 2016;87:024301. [DOI: 10.1063/1.4941776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
12 Sun X, Nunes SS. Bioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes. Front Cell Dev Biol 2017;5:19. [PMID: 28337437 DOI: 10.3389/fcell.2017.00019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
13 Scott CW, Peters MF, Dragan YP. Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. Toxicol Lett. 2013;219:49-58. [PMID: 23470867 DOI: 10.1016/j.toxlet.2013.02.020] [Cited by in Crossref: 111] [Cited by in F6Publishing: 89] [Article Influence: 13.9] [Reference Citation Analysis]
14 Laksman Z, Wauchop M, Lin E, Protze S, Lee J, Yang W, Izaddoustdar F, Shafaattalab S, Gepstein L, Tibbits GF, Keller G, Backx PH. Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue. Sci Rep 2017;7:5268. [PMID: 28706272 DOI: 10.1038/s41598-017-05652-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
15 Devalla HD, Schwach V, Ford JW, Milnes JT, El-Haou S, Jackson C, Gkatzis K, Elliott DA, Chuva de Sousa Lopes SM, Mummery CL, Verkerk AO, Passier R. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. EMBO Mol Med 2015;7:394-410. [PMID: 25700171 DOI: 10.15252/emmm.201404757] [Cited by in Crossref: 189] [Cited by in F6Publishing: 172] [Article Influence: 31.5] [Reference Citation Analysis]
16 Samak M, Hinkel R. Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects. Cells 2019;8:E1530. [PMID: 31783680 DOI: 10.3390/cells8121530] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
17 Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B, Jiang J, Massé S, Gagliardi M, Hsieh A, Thavandiran N, Laflamme MA, Nanthakumar K, Gross GJ, Backx PH, Keller G, Radisic M. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 2013;10:781-7. [PMID: 23793239 DOI: 10.1038/nmeth.2524] [Cited by in Crossref: 543] [Cited by in F6Publishing: 502] [Article Influence: 67.9] [Reference Citation Analysis]
18 Zhu R, Blazeski A, Poon E, Costa KD, Tung L, Boheler KR. Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 2014;5:117. [PMID: 25688759 DOI: 10.1186/scrt507] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 9.9] [Reference Citation Analysis]
19 Chang Liao ML, de Boer TP, Mutoh H, Raad N, Richter C, Wagner E, Downie BR, Unsöld B, Arooj I, Streckfuss-Bömeke K, Döker S, Luther S, Guan K, Wagner S, Lehnart SE, Maier LS, Stühmer W, Wettwer E, van Veen T, Morlock MM, Knöpfel T, Zimmermann WH. Sensing Cardiac Electrical Activity With a Cardiac Myocyte--Targeted Optogenetic Voltage Indicator. Circ Res 2015;117:401-12. [PMID: 26078285 DOI: 10.1161/CIRCRESAHA.117.306143] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
20 Menasché P, Vanneaux V, Fabreguettes JR, Bel A, Tosca L, Garcia S, Bellamy V, Farouz Y, Pouly J, Damour O, Périer MC, Desnos M, Hagège A, Agbulut O, Bruneval P, Tachdjian G, Trouvin JH, Larghero J. Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. Eur Heart J 2015;36:743-50. [PMID: 24835485 DOI: 10.1093/eurheartj/ehu192] [Cited by in Crossref: 111] [Cited by in F6Publishing: 101] [Article Influence: 15.9] [Reference Citation Analysis]
21 Miklas JW, Nunes SS, Radisic M. Engineering Cardiac Tissues from Pluripotent Stem Cells for Drug Screening and Studies of Cell Maturation. Isr J Chem 2013. [DOI: 10.1002/ijch.201300064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Kofron CM, Mende U. In vitro models of the cardiac microenvironment to study myocyte and non-myocyte crosstalk: bioinspired approaches beyond the polystyrene dish. J Physiol 2017;595:3891-905. [PMID: 28116799 DOI: 10.1113/JP273100] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
23 Fleischer S, Jahnke HG, Fritsche E, Girard M, Robitzki AA. Comprehensive human stem cell differentiation in a 2D and 3D mode to cardiomyocytes for long-term cultivation and multiparametric monitoring on a multimodal microelectrode array setup. Biosens Bioelectron 2019;126:624-31. [PMID: 30508787 DOI: 10.1016/j.bios.2018.10.061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
24 Kohl P, Bollensdorff C, Morad M. Progress in Biophysics and Molecular Biology of the Beating Heart. Progress in Biophysics and Molecular Biology 2012;110:151-3. [DOI: 10.1016/j.pbiomolbio.2012.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Nakanishi H, Lee JK, Miwa K, Masuyama K, Yasutake H, Li J, Tomoyama S, Honda Y, Deguchi J, Tsujimoto S, Hidaka K, Miyagawa S, Sawa Y, Komuro I, Sakata Y. Geometrical Patterning and Constituent Cell Heterogeneity Facilitate Electrical Conduction Disturbances in a Human Induced Pluripotent Stem Cell-Based Platform: An In vitro Disease Model of Atrial Arrhythmias. Front Physiol 2019;10:818. [PMID: 31316396 DOI: 10.3389/fphys.2019.00818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Huang J, Liu Y, Chen JX, Lu XY, Zhu WJ, Qin L, Xun ZX, Zheng QY, Li EM, Sun N, Xu C, Chen HY. Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy. Acta Pharmacol Sin 2021. [PMID: 33785860 DOI: 10.1038/s41401-021-00639-y] [Reference Citation Analysis]
27 van den Heuvel NH, van Veen TA, Lim B, Jonsson MK. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes. J Mol Cell Cardiol 2014;67:12-25. [PMID: 24370890 DOI: 10.1016/j.yjmcc.2013.12.011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
28 Vestergaard ML, Grubb S, Koefoed K, Anderson-Jenkins Z, Grunnet-Lauridsen K, Calloe K, Clausen C, Christensen ST, Møllgård K, Andersen CY. Human Embryonic Stem Cell-Derived Cardiomyocytes Self-Arrange with Areas of Different Subtypes During Differentiation. Stem Cells Dev 2017;26:1566-77. [PMID: 28795648 DOI: 10.1089/scd.2017.0054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
29 Zhang J, Chou OH, Tse YL, Ng KM, Tse HF. Application of Patient-Specific iPSCs for Modelling and Treatment of X-Linked Cardiomyopathies. Int J Mol Sci 2021;22:8132. [PMID: 34360897 DOI: 10.3390/ijms22158132] [Reference Citation Analysis]
30 Gorospe G, Zhu R, Millrod MA, Zambidis ET, Tung L, Vidal R. Automated grouping of action potentials of human embryonic stem cell-derived cardiomyocytes. IEEE Trans Biomed Eng 2014;61:2389-95. [PMID: 25148658 DOI: 10.1109/TBME.2014.2311387] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
31 Shen N, Knopf A, Westendorf C, Kraushaar U, Riedl J, Bauer H, Pöschel S, Layland SL, Holeiter M, Knolle S, Brauchle E, Nsair A, Hinderer S, Schenke-Layland K. Steps toward Maturation of Embryonic Stem Cell-Derived Cardiomyocytes by Defined Physical Signals. Stem Cell Reports 2017;9:122-35. [PMID: 28528699 DOI: 10.1016/j.stemcr.2017.04.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
32 Joshi-Mukherjee R, Dick IE, Liu T, O'Rourke B, Yue DT, Tung L. Structural and functional plasticity in long-term cultures of adult ventricular myocytes. J Mol Cell Cardiol 2013;65:76-87. [PMID: 24076394 DOI: 10.1016/j.yjmcc.2013.09.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
33 Lu HR, Whittaker R, Price JH, Vega R, Pfeiffer ER, Cerignoli F, Towart R, Gallacher DJ. High Throughput Measurement of Ca ++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds. Toxicol Sci 2015;148:503-16. [DOI: 10.1093/toxsci/kfv201] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 10.7] [Reference Citation Analysis]
34 Pilarczyk G, Raulf A, Gunkel M, Fleischmann BK, Lemor R, Hausmann M. Tissue-Mimicking Geometrical Constraints Stimulate Tissue-Like Constitution and Activity of Mouse Neonatal and Human-Induced Pluripotent Stem Cell-Derived Cardiac Myocytes. J Funct Biomater 2016;7:E1. [PMID: 26751484 DOI: 10.3390/jfb7010001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Murphy SA, Chen EZ, Tung L, Boheler KR, Kwon C. Maturing heart muscle cells: Mechanisms and transcriptomic insights. Semin Cell Dev Biol 2021:S1084-9521(21)00092-6. [PMID: 33952430 DOI: 10.1016/j.semcdb.2021.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Yang H, Zhang M, Huang J, Liang H, Zhang P, Boheler KR. Cardiomyocytes derived from pluripotent stem cells: Progress and prospects from China. Experimental Cell Research 2013;319:120-5. [DOI: 10.1016/j.yexcr.2012.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Wang Y, Zhu R, Tung L. Contribution of potassium channels to action potential repolarization of human embryonic stem cell-derived cardiomyocytes. Br J Pharmacol 2019;176:2780-94. [PMID: 31074016 DOI: 10.1111/bph.14704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Hou J, Zhou C, Long H, Zheng S, Guo T, Wu Q, Wu H, Zhong T, Wang T. Long noncoding RNAs: Novel molecules in cardiovascular biology, disease and regeneration. Exp Mol Pathol 2016;100:493-501. [PMID: 27180105 DOI: 10.1016/j.yexmp.2016.05.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
39 Bektik E, Cowan DB, Wang DZ. Long Non-Coding RNAs in Atrial Fibrillation: Pluripotent Stem Cell-Derived Cardiomyocytes as a Model System. Int J Mol Sci 2020;21:E5424. [PMID: 32751460 DOI: 10.3390/ijms21155424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Kang C, Qiao Y, Li G, Baechle K, Camelliti P, Rentschler S, Efimov IR. Human Organotypic Cultured Cardiac Slices: New Platform For High Throughput Preclinical Human Trials. Sci Rep 2016;6:28798. [PMID: 27356882 DOI: 10.1038/srep28798] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
41 Yan Y, Liu F, Dang X, Zhou R, Liao B. TBX3 induces biased differentiation of human induced pluripotent stem cells into cardiac pacemaker-like cells. Gene Expr Patterns 2021;40:119184. [PMID: 33975000 DOI: 10.1016/j.gep.2021.119184] [Reference Citation Analysis]
42 Kumar S, Teh AW, Medi C, Kistler PM, Morton JB, Kalman JM. Atrial remodeling in varying clinical substrates within beating human hearts: Relevance to atrial fibrillation. Progress in Biophysics and Molecular Biology 2012;110:278-94. [DOI: 10.1016/j.pbiomolbio.2012.07.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
43 Du DT, Hellen N, Kane C, Terracciano CM. Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density. Biophys J 2015;108:1-4. [PMID: 25564842 DOI: 10.1016/j.bpj.2014.11.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 10.2] [Reference Citation Analysis]
44 Spearman BS, Hodge AJ, Porter JL, Hardy JG, Davis ZD, Xu T, Zhang X, Schmidt CE, Hamilton MC, Lipke EA. Conductive interpenetrating networks of polypyrrole and polycaprolactone encourage electrophysiological development of cardiac cells. Acta Biomaterialia 2015;28:109-20. [DOI: 10.1016/j.actbio.2015.09.025] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 13.3] [Reference Citation Analysis]
45 Gintant G, Sager PT, Stockbridge N. Evolution of strategies to improve preclinical cardiac safety testing. Nat Rev Drug Discov 2016;15:457-71. [DOI: 10.1038/nrd.2015.34] [Cited by in Crossref: 234] [Cited by in F6Publishing: 204] [Article Influence: 46.8] [Reference Citation Analysis]
46 Dell’Era P, Benzoni P, Crescini E, Valle M, Xia E, Consiglio A, Memo M. Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes. World J Stem Cells 2015; 7(2): 329-342 [PMID: 25815118 DOI: 10.4252/wjsc.v7.i2.329] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
47 Zhu R, Millrod MA, Zambidis ET, Tung L. Variability of Action Potentials Within and Among Cardiac Cell Clusters Derived from Human Embryonic Stem Cells. Sci Rep 2016;6:18544. [PMID: 26729331 DOI: 10.1038/srep18544] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
48 Chiamvimonvat N, Chen-Izu Y, Clancy CE, Deschenes I, Dobrev D, Heijman J, Izu L, Qu Z, Ripplinger CM, Vandenberg JI, Weiss JN, Koren G, Banyasz T, Grandi E, Sanguinetti MC, Bers DM, Nerbonne JM. Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics. J Physiol 2017;595:2229-52. [PMID: 27808412 DOI: 10.1113/JP272883] [Cited by in Crossref: 44] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
49 Shafaattalab S, Lin E, Christidi E, Huang H, Nartiss Y, Garcia A, Lee J, Protze S, Keller G, Brunham L, Tibbits GF, Laksman Z. Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes. Stem Cell Reports 2019;12:996-1006. [PMID: 31031187 DOI: 10.1016/j.stemcr.2019.03.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
50 Hochman-Mendez C, Pereira de Campos DB, Pinto RS, Mendes BJDS, Rocha GM, Monnerat G, Weissmuller G, Sampaio LC, Carvalho AB, Taylor DA, de Carvalho ACC. Tissue-engineered human embryonic stem cell-containing cardiac patches: evaluating recellularization of decellularized matrix. J Tissue Eng 2020;11:2041731420921482. [PMID: 32742631 DOI: 10.1177/2041731420921482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]